TOPICAL TREATMENT OF LOCALIZED SCLERODERMA

Disclosed are compositions and formulations for topical administration that contain a tyrosin kinase inhibitor, such as imatinib or nilotinib. The topical compositions or formulations are useful in treating scleroderma.

Saved in:
Bibliographic Details
Main Authors TRUMBORE, MARK, W, LAFYATIS, ROBERT, ALAN, MAJHI, PINAKI, RANJAN, REDMON, MARTIN, P
Format Patent
LanguageEnglish
French
German
Published 18.05.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compositions and formulations for topical administration that contain a tyrosin kinase inhibitor, such as imatinib or nilotinib. The topical compositions or formulations are useful in treating scleroderma.
Bibliography:Application Number: EP20140822588